Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming

Research output: Contribution to journalLetterResearchpeer-review

DOI

  1. Increased vulnerability to Covid-19 in chronic kidney disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Preheart failure comorbidities and impact on prognosis in heart failure patients: a nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Coffee intake protects against symptomatic gallstone disease in the general population: a Mendelian randomization study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Phenotypic and genotypic differences between Indian and Scandinavian women with gestational diabetes mellitus

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Coagulation parameters in the newborn and infant - the Copenhagen Baby Heart and COMPARE studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalJournal of Internal Medicine
Volume290
Issue number6
Pages (from-to)1272-1274
Number of pages3
ISSN0954-6820
DOIs
Publication statusPublished - Dec 2021

    Research areas

  • antibody neutralization, antibody response, BNT162b2, COVID-19, IgA, IgG, IgM, immunoassays, nucleocapsid protein, RBD, SARS-CoV-2, serology, vaccine

ID: 69224227